.@aditxt $ADTX Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025.#StocksToWatch #stocksinnews #investors #smallcaps .

.@aditXt (Nasdaq: $ADTX), Inc. Regains Compliance with Nasdaq Listing Requirements.#stockstowatch #stocksinnews #investor #daytrader.

What do you want to know?.

.@aditxt $ADTX Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk.#Cancer #investors

Join Aditxt’s (NASDAQ:ADTX) Fireside Chat Friday, Feb 21 @ 11:30 AM ET.CEO Amro Albanna will provide company update including key developments across Adimune, Pearsanta, and upcoming initiatives. Submit Qs by Feb 20 5PM ET: engagement@aditxt.com.

🌍 In South Sudan, girls are more likely to die in childbirth than finish school. 300K maternal deaths in 2020 @DFID_UK reports. @Evofem's Phexxi® leads in non-hormonal contraception, empowering women's reproductive health.

Final Call to Join Our Investor Event Today!. Amro Albanna will provide an overview of our plans for 2024 and the promising innovations showcasing our commitment to tackling complex health challenges. Don't miss this chance to be a part of our journey. Last chance to register

RT @RichmondInno: Richmond life sciences company Aditxt Inc. is dipping into the M&A waters for the second time in a month. .

Today is a day to celebrate Dr. Martin Luther King Jr. and his impact on civil rights and social justice. We also recognize that his actions and methods were a form of innovation within the social context of his time. His foresight in combining moral vision with strategic

You don’t wear a car seat belt for protection when you’re not in a car…. Why daily birth control?. Since 1960, that's been the norm, but every day isn't 'that day'. Meet Phexxi: The birth control revolution! Take charge only when needed - say goodbye to daily doses!. Time for

Shocking data from @UNFPA Almost half of all global pregnancies (121M annually) are unintended. Innovation is crucial in addressing this. Enter @Evofem Phexxi: Empowering women with reproductive health choices. We're committed to Phexxi's success, enhancing accessibility &

Aditxt’s recently signed a definitive agreement to acquire @Evofem in a $100M transaction. We’re thrilled to re-share their news that Phexxi, a hormone-free contraceptive, is now available on Washington Medicaid plans without Prior Authorization. This change affects 1.8

Aditxt subsidiary Pearsanta acquires MDNA's Mitomic™ Platform for $25M! Aiming at major strides in women's & men's health, and entering the booming liquid biopsy market. 🧬. Key Features:.Precision diagnostics using mitochondrial DNA. Early, non-invasive disease detection.

We're driven to innovate for life-changing solutions. But it's stories like Kayla's, battling lung transplantation, that truly highlight our mission. Her journey is a poignant example of the lives we touch & the urgency of our work. That's our motivation every day. To make a

RT @PsoriasisUK: "I've become more empathetic towards others, I've learnt patience is key. It's not easy. But I don't want to hide anymore….

We've recently announced we have signed a Definitive Agreement to acquire @Evofem creators of Phexxi - the ONLY FDA-approved, non-hormonal contraceptive gel for women. If you haven’t seen their CEO’s @TEDxSanDiego presentation, it’s a must-watch! Saundra's informative.

Thanks to @mariaaspan from @FortuneMagazine for speaking with Amro & Saundra from @Evofem about the recent announcement. We recognize Evofem's incredible potential, we're committed to ensuring its sustained success as a promising innovation, expanding accessibility to women.

Exciting news at Aditxt (NASDAQ: ADTX)! 🚀. We're thrilled to share that we’ve signed a definitive agreement to acquire @Evofem Biosciences, Inc., makers of Phexxi®—the only FDA-approved hormone-free contraceptive gel. Phexxi empowers women in a revolutionary way. This on-demand

A ‘bionic pancreas’ that combines an insulin pump and automated dosing software has been approved by the US Food and Drugs Administration (FDA) for use by people living with #TypeOne diabetes in the US. #Innovation.

"When you are in foreign country, it can be difficult to navigate the healthcare and insurance system of the country you are visiting or working in." Read how @Medinaction has innovated to provide services for those in need. Via @Forbes #HealthCare.

RT @MicrocapsNews: Aditxt,® Inc. (NASDAQ: $ADTX)’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and….